Integrating Buprenorphine for Opioid Use Disorder into Rural, Primary Care Settings

被引:1
|
作者
Wyse, Jessica J. [1 ,2 ]
Eckhardt, Alison [1 ]
Newell, Summer [1 ]
Gordon, Adam J. [3 ,4 ,5 ]
Morasco, Benjamin J. [1 ,6 ]
Carlson, Kathleen [1 ,2 ]
Korthuis, P. Todd [2 ,7 ]
Ono, Sarah S. [1 ,6 ,8 ]
Lovejoy, Travis I. [1 ,6 ,8 ]
机构
[1] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA
[2] OHSU PSU, Sch Publ Hlth, 1810 SW 5th Ave,Suite 510, Portland, OR 97201 USA
[3] VA Salt Lake City Hlth Care Syst, Analyt Sci IDEAS Ctr, Informat Decis Enhancement, 500 Foothill Dr, Salt Lake City, UT 84148 USA
[4] Univ Utah, Div Epidemiol, Sch Med, 295 Chipeta Way, Salt Lake City, UT 84132 USA
[5] Univ Utah, Dept Internal Med, Sch Med, 295 Chipeta Way, Salt Lake City, UT 84132 USA
[6] Oregon Hlth & Sci Univ, Dept Psychiat, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
[7] Oregon Hlth & Sci Univ, Dept Med, Div Gen Internal Med & Geriatr, Sect Addict Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
[8] Vet Rural Hlth Resource Ctr Portland, VA Off Rural Hlth, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA
关键词
rural; veterans; access; opioid agonist; opioid use disorder; MEDICATION TREATMENT; BARRIERS; ACCESS; FACILITATORS; MODEL;
D O I
10.1007/s11606-024-08898-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundMedications for opioid use disorder (MOUD) including buprenorphine are effective, but underutilized. Rural patients experience pronounced disparities in access. To reach rural patients, the US Department of Veterans Affairs (VA) has sought to expand buprenorphine prescribing beyond specialty settings and into primary care.ObjectiveAlthough challenges remain, some rural VA health care systems have begun offering opioid use disorder (OUD) treatment with buprenorphine in primary care. We conducted interviews with clinicians, leaders, and staff within these systems to understand how this outcome had been achieved.DesignUsing administrative data from the VA Corporate Data Warehouse (CDW), we identified rural VA health care systems that had improved their rate of primary care-based buprenorphine prescribing over the period 2015-2020. We conducted qualitative interviews (n = 30) with staff involved in implementing or prescribing buprenorphine in these systems to understand the processes that had facilitated implementation.ParticipantsClinicians, staff, and leaders embedded within rural VA health care systems located in the Northwest, West, Midwest (2), South, and Northeast.ApproachQualitative interviews were analyzed using a mixed inductive/deductive approach.Key ResultsInterviews revealed the processes through which buprenorphine was integrated into primary care, as well as processes insufficient to enact change. Implementation was often initially catalyzed through a targeted hire. Champions then engaged clinicians and leaders one-on-one to "pitch" the case, describe concordance between buprenorphine prescribing and existing goals, and delineate the supportive role that they could provide. Sites were prepared for implementation by developing new clinical teams and redesigning clinical processes. Each of these processes was made possible with the active, instrumental support of leadership.ConclusionsResults suggest that rural systems seeking to improve buprenorphine accessibility in primary care may need to alter primary care structures to accommodate buprenorphine prescribing, whether through new hires, team development, or clinical redesign.
引用
收藏
页码:2142 / 2149
页数:8
相关论文
共 50 条
  • [31] Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network
    Lepine, Barbara
    Debin, Marion
    Dassieu, Lise
    Gimenez, Laetitia
    Palmaro, Aurore
    Ponte, Camille
    Swital, Morgane
    Lapeyre-Mestre, Maryse
    Blanchon, Thierry
    Dupouy, Julie
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 143
  • [32] Co-occurring substance use disorders among patients with opioid use disorder in rural primary care clinics
    Zhu, Yuhui
    Baldwin, Laura-Mae
    Mooney, Larissa J.
    Saxon, Andrew J.
    Kan, Emily
    Hser, Yih-Ing
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 158
  • [33] Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy
    Perry, Briana N.
    Vais, Simone
    Boateng, Jeffery O.
    Jain, Mayuri
    Wachman, Elisha M.
    Saia, Kelley A.
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (06) : E389 - E394
  • [34] Barriers to Buprenorphine Prescribing for Opioid Use Disorder in Hospice and Palliative Care
    Ho, Jiunling Janet
    Jones, Katie Fitzgerald
    Sager, Zachary
    Neale, Kyle
    Childers, Julie W.
    Loggers, Elizabeth
    Merlin, Jessica S.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2022, 64 (02) : 119 - 127
  • [35] PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment
    Campbell, Cynthia I.
    Saxon, Andrew J.
    Boudreau, Denise M.
    Wartko, Paige D.
    Bobb, Jennifer F.
    Lee, Amy K.
    Matthews, Abigail G.
    McCormack, Jennifer
    Liu, David S.
    Addis, Megan
    Altschuler, Andrea
    Samet, Jeffrey H.
    LaBelle, Colleen T.
    Arnsten, Julia
    Caldeiro, Ryan M.
    Borst, Douglas T.
    Stotts, Angela L.
    Braciszewski, Jordan M.
    Szapocznik, Jose
    Bart, Gavin
    Schwartz, Robert P.
    McNeely, Jennifer
    Liebschutz, Jane M.
    Tsui, Judith I.
    Merrill, Joseph O.
    Glass, Joseph E.
    Lapham, Gwen T.
    Murphy, Sean M.
    Weinstein, Zoe M.
    Yarborough, Bobbi Jo H.
    Bradley, Katharine A.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
  • [36] Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings
    Ellis, Matthew S.
    Kasper, Zachary A.
    Cicero, Theodore J.
    PREVENTIVE MEDICINE, 2021, 152
  • [37] Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report
    Hagan, Scott
    Achtmeyer, Carol E.
    Hood, Carly
    Hawkins, Eric J.
    Williams, Emily C.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
  • [38] Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report
    Scott Hagan
    Carol E. Achtmeyer
    Carly Hood
    Eric J. Hawkins
    Emily C. Williams
    Addiction Science & Clinical Practice, 16
  • [39] Integrating episodes of imprisonment and the cascade of care for opioid use disorder
    Cossar, Reece D.
    Stewart, Ashleigh C.
    Winter, Rebecca
    Curtis, Michael
    Dietze, Paul M.
    Ogloff, James R. P.
    Stoove, Mark
    ADDICTION, 2021, 116 (02) : 427 - 428
  • [40] Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine
    Brunet, Nicole
    Moore, David T.
    Lendvai Wischik, Dora
    Mattocks, Kristin M.
    Rosen, Marc I.
    SUBSTANCE ABUSE, 2022, 43 (01) : 39 - 46